| Common Stock, Shares Authorized |
2,000,000,000 |
shares |
|
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
5,880,763 |
shares |
|
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$15,828,000 |
USD |
68717% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,014,000 |
USD |
47% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$937,000 |
USD |
48% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
-100% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
0 |
shares |
-100% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$23,618,000 |
USD |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
-100% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,014,000 |
USD |
47% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q4 2024 |
FY 2024 |